NEWS FLASH

Unaudited financial results for the quarter ended December 31, 2007

Unaudited financial results for the quarter ended 30th September, 2007

Unaudited financial results for the quarter ended 30th June, 2007

Ind-Swift Laboratories Limited undergoes successful USFDA audit


Click here to view Mint Products
Ind-Swift Laboratories is a part of the Ind-Swift group and is based at Chandigarh, India. It has been promoted by Ind-Swift Limited in joint venture with the Punjab State industrial Development Corporation Limited (PSIDC).

The group has established a strong reputation as innovators in the Indian pharmaceutical industry.
 
 
MANUFACTURING
RESEARCH &
DEVELOPMENT
BUSINESS
OPPORTUNITIES
     
Stricitly Operating in accordance with GMP and withregard to Documentation
A number of new molecules including Pioglitazone, Candesartan and Citalopram are already in pipeline
ISLL is positioning itself as a
primary supplier of APIs to generic players in Advanced Markets
more
more
more
         
Ind-Swift Laboratories Limited undergoes successful USFDA audit

Ind-Swift Laboratories Ltd. has successfully completed USFDA inspection for  Clarithromycin, Active Pharmaceutical Ingredient (API) manufacturing facility. Ind-Swift Laboratories Inc. USA ( ISL INC.), a wholly owned subsidiary of Ind-Swift Laboratories was instrumental in achieving this milestone, said N.R. Munjal, Managing Director. Read more
Ind-Swift labs inaugurates its state of the Art R&D center.To focus on CRAMS and regulated markets

Re-inforcing its focus on Research and Development, the company has put to operation its state of the art R&D center . The new R&D Centre which is located at Mohlai, Punjab

To know about our Formulation Division, please visit us at Ind-Swift Limited, our other group company.
Copyright©2001 Ind-Swift Laboratories Limited. All rights reserved.